Amyloidosis

Overview of amyloid disorders.

Reviewed by Dr Kola Tytler MBBS CertHE MBA MRCGP (General Practitioner)
Last reviewed: 21 October 2025
HaematologyCardiologyNephrology

Clinical Guidelines

ESC Guidelines for the diagnosis and management of cardiac amyloidosis
National
Guidelines on AL Amyloidosis - The European Hematology Association
National
NICE Technology Appraisal Guidance [TA959]: Daratumumab in combination for treating newly diagnosed systemic amyloid light-chain amyloidosis
National
2022 ACC/AHA/HFSA Guideline for the Management of Heart Failure
Local
2023 ACC Expert Consensus Decision Pathway on Comprehensive Multidisciplinary Care for the Patient With Cardiac Amyloidosis
Local
ASH Clinical Practice Guidelines: Amyloidosis
Local
ASNC/AHA/ASE/EANM/HFSA/ISA/SCMR/SNMMI Expert Consensus Recommendations For Multimodality Imaging in Cardiac Amyloidosis
Local
Cardiac Amyloidosis: Evolving Diagnosis and Management: A Scientific Statement From the American Heart Association
Local
Diagnosis and treatment of cardiac amyloidosis: a position statement of the ESC Working Group on Myocardial and Pericardial Diseases
Local
NCCN Clinical Practice Guidelines in Oncology: Systemic Light Chain Amyloidosis. Version: 1.2026
Local
Non-amyloid specific treatment for transthyretin cardiac amyloidosis: a clinical consensus statement of the ESC Heart Failure Association
Local
Treatment of AL Amyloidosis: Mayo Stratification of Myeloma and Risk-Adapted Therapy (mSMART) Consensus Statement 2020 Update
Local
World Heart Federation Consensus on Transthyretin Amyloidosis
Local